Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease
2014
Mitochondrial Adaptations to Obesity-Related Oxidant Stress
2000
Use of antimicrobials for EUS-guided FNA of pancreatic cysts: a retrospective, comparative analysis
2011
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Hepatocellular carcinoma
2003 Standout
Non‐alcoholic steatohepatitis: Definitions and pathogenesis
2002
Pancreatic cancer
2004 Standout
Pancreas Divisum Is Not a Cause of Pancreatitis by Itself But Acts as a Partner of Genetic Mutations
2011
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
2004
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
1997
Liver fibrosis
2005 Standout
Hepatocellular carcinoma
2018 Standout
Hepatitis C Virus Infection
2001 Standout
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron-related chronic liver disease
2001
A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France
2012
Nonalcoholic fatty liver disease
2002
Pancreatic cancer
2020 Standout
Burden of liver diseases in the world
2018 Standout
Steatosis: Co-factor in Other Liver Diseases *
2005
Liver cirrhosis
2014
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Risk factors of fibrosis in alcohol-induced liver disease
2002
Pancreatic cancer
2016 Standout
Hepatocellular carcinoma
2012 Standout
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
2011
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease
2011
Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)
2002
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Update on Nonalcoholic Fatty Liver Disease
2002
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Acute Pancreatitis
2016 Standout
From NAFLD in clinical practice to answers from guidelines
2013
Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK
2011
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Liver fibrosis in overweight patients
2000
Leptin Augments Inflammatory and Profibrogenic Responses in the Murine Liver Induced by Hepatotoxic Chemicals
2001
Screening for Early Pancreatic Neoplasia in High-Risk Individuals: A Prospective Controlled Study
2006
Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas
2006
Liver Transplantation for Hepatocellular Carcinoma
2008
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
1996
Non-alcoholic fatty liver disease
2021 Standout
A comparison of fibrosis progression in chronic liver diseases
2003
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Hepatitis C virus and hepatocellualr carcinoma
1994
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
2010
Long term prognosis of fatty liver: risk of chronic liver disease and death
2004
Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies
2010
Evolving Preoperative Evaluation of Patients with Pancreatic Cancer: Does Laparoscopy Have a Role in the Current Era?
2008
Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide
2016
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
2003
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features
2007
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies
2013
The role of AMP-activated protein kinase in the action of ethanol in the liver
2004
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Alterations in Liver ATP Homeostasis in Human Nonalcoholic Steatohepatitis
1999
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Leptin receptor–mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat
2002
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Treatment of Alcoholic Liver Disease
2005
Pancreatic Cancer
2010 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
1997
Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model
2006
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
1994
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Early detection of pancreatic cancer
2020
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
2003
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
2012 Standout
Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options
2007
Hepatocellular Carcinoma
2011 Standout
Global challenges in liver disease
2006
Alcoholic Liver Disease
2009
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis
2011
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and Women
2002
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
Pancreatic cancer
2011 Standout
Alcoholic steatohepatitis
2010
Replication of hepatitis C virus
2007 StandoutNobel
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
2001
Evaluation of Liver Fibrosis: A Concise Review
2004
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
2000
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
2017
Alcoholic Hepatitis
2009
Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues
2008
II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin
1998
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Increased Risk of Hepatocellular Carcinoma and Liver Cirrhosis in Vinyl Chloride Workers: Synergistic Effect of Occupational Exposure with Alcohol Intake
2004
Prevelance of abnormal serum aminotransferase values in overweight and obese adolescents
2000
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
An adipocentric view of liver fibrosis and cirrhosis.
2004
Liver organ allocation for hepatocellular carcinoma: Are we sure?
2003
Nonalcoholic Fatty Liver Disease
2015 Standout
Screening for Pancreatic Cancer in High-Risk Individuals: A Call for Endoscopic Ultrasound
2009
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Works of Alain Aubert being referenced
Acute Pancreatitis in Patients Operated on for Intraductal Papillary Mucinous Neoplasms of the Pancreas
2010
Apolipoprotein A1 is a Serum and Tissue Marker of Liver Fibrosis in Alcoholic Patients
1989
Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas
2006
Natural History of Intraductal Papillary Mucinous Tumors of the Pancreas: Actuarial Risk of Malignancy
2006
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Performance of Pancreatic Fluid Analysis for Positive Diagnosis and the Prediction of Malignancy
2008
Assessment of complications of EUS-guided fine-needle aspiration
2001
Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled withKRASmutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis
2009
Morphologic Changes in Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Midterm Follow-Up Study
2008
Excess Weight Risk Factor for Alcoholic Liver Disease
1997
Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis
2003
Independent risk factors for hepatocellular carcinoma in french drinkers
1991
A Simple Biological Index for Detection of Alcoholic Liver Disease in Drinkers
1991
A simple biological index for detection of alcoholic liver disease in drinkers.
1991
Needle-based confocal laser endomicroscopy of pancreatic cystic lesions: a prospective multicenter validation study in patients with definite diagnosis
2018